Last week, BioMarin Pharmaceutical Inc. revealed changes to its C-suite; now, the company has announced its second round of layoffs this year, following the termination of 170 employees in May. https://hubs.li/Q02N55Mr0 #pharma #biospace
BioSpace
Internet News
West Des Moines, Iowa 116,092 followers
The leading source for biopharma news and jobs. Connecting industry pioneers with talented professionals.
Über uns
BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe.
- Website
-
http://www.biospace.com/
External link for BioSpace
- Industrie
- Internet News
- Größe des Unternehmens
- 11-50 Mitarbeiter
- Hauptsitz
- West Des Moines, Iowa
- Typ
- In Privatbesitz
- Gegründet
- 1985
- Spezialitäten
- biotech jobs, pharma jobs, biotech news, pharma news, and life sciences news
Standorte
-
Primäre
3001 Westown Pkwy
#101
West Des Moines, Iowa 50266, US
Employees at BioSpace
-
Greg Slabodkin
-
Dr. D. Martin Alexander Gershon, MD, JD, MPH
AI & Digital Health Innovation Keynote•Linkedin “Top Voice” Venture Capital, Entrepreneurship, & Fundraising•Techstars Sr EIR•Goldman…
-
Angela Gabriel
Content Manager (Life Sciences Careers) at BioSpace
-
Lori Ellis (Katz)
Head of Insights
Aktualisierungen
-
In Texas, the Plano City Council approved a development agreement that supports a planned project that would bring over 3 million square feet of life sciences space to the area. https://hubs.li/Q02N54lv0 #pharma #biospace
Texas Life Sciences Redevelopment Project Moves Closer to Reality
biospace.com
-
Merck continued its clinical losing streak on Thursday with the announcement that it is discontinuing late-stage studies of the anti-PD-1 therapy in non-small cell lung cancer and cutaneous squamous cell carcinoma. https://hubs.li/Q02N2PkT0 #pharma #biospace
Merck Axes Two Keytruda Phase III Cancer Trials Due to Disappointing Data
biospace.com
-
Rep. James Comer (R-Ky.), chair of the House Committee on Oversight and Accountability, wants the CEOs of CVS Caremark, Express Scripts and Optum Rx—three major pharmacy benefit managers—to correct statements they made during a hearing last month. https://hubs.li/Q02N1Zkx0 #pharma #biospace
House Oversight Chair Calls on PBM Execs to Correct Testimonies
biospace.com
-
In its legal complaint, filed in the District Court for New Jersey, Regeneron alleges that Sandoz failed to provide it with relevant information required under the Biologics Price Competition and Innovation Act. https://hubs.li/Q02N25Vl0 #pharma #biospace
Regeneron Sues Sandoz in Federal Court to Block Eylea Biosimilar
biospace.com
-
Don't miss out on your chance to vote in BioSpace's Best Places to Work in Life Sciences, 2025! Voting closes August 31st. https://hubs.li/Q02N1-5z0 #bestplacestowork #pharma #biotech #biopharma #lifesciences #biospace
-
-
In this episode, the third and final conversation of our mini-series on diversity in clinical trials, Lori Ellis (Katz) and guests Otis Johnson, PhD, MPA of Trial Equity, Pamela Tenaerts, MD, MBA of Medable, Inc, Christopher Escobedo Hart of Foley Hoag LLP, Patrick Floody of Regeneron, and Ken Getz of Tufts Center for the Study of Drug Development discuss framing strategies designed to protect DEI initiatives from legal challenges. https://hubs.li/Q02N1q6Q0 #pharma #podcast #biospace
Future-Proofing: Inclusive and Protective Patient Strategies
biospace.com
-
Armed with new late-stage data on reducing low-density lipoprotein cholesterol, Novartis is positioning its siRNA therapy Leqvio as a preventive treatment for atherosclerotic cardiovascular disease. https://hubs.li/Q02N0XMs0 #pharma #biospace
Novartis Plots Leqvio Expansion After Lowering Cholesterol in Phase III Study
-
Neurocrine Biosciences' potential competitor to Bristol Myers Squibb's KarXT improved symptoms of schizophrenia in a Phase II trial, but only at the low dose tested. #pharma #biospace https://hubs.li/Q02MWcv60
Neurocrine Shares Drop 20% Despite Meeting Primary Endpoint in Mid-Stage Schizophrenia Trial
-
Congress, the Federal Trade Commission and the U.S. Patent and Trademark Office are all targeting Big Pharma’s practice of filing multiple, overlapping patents that stifle generic and biosimilar competition. #ftc #congress #pharmanews #biospace https://hubs.li/Q02MVQ0f0
Patent Thickets in Federal Government’s Crosshairs as Election 2024 Looms
biospace.com